All Stories

  1. CD200 as a Potential New Player in Inflammation during Rotator Cuff Tendon Injury/Repair: An In Vitro Model
  2. Hyaluronic Acid Alleviates Oxidative Stress and Apoptosis in Human Tenocytes via Caspase 3 and 7
  3. The Impact of Hyaluronic Acid on Tendon Physiology and Its Clinical Application in Tendinopathies
  4. Identification of circulating CD31+CD45+ cell populations with the potential to differentiate into erythroid cells
  5. Dual Acting Carbon Monoxide Releasing Molecules and Carbonic Anhydrase Inhibitors Differentially Modulate Inflammation in Human Tenocytes
  6. Conjugation with Methylsulfonylmethane Improves Hyaluronic Acid Anti-Inflammatory Activity in a Hydrogen Peroxide-Exposed Tenocyte Culture In Vitro Model
  7. Expression profiling of microRNAs and isomiRs in conventional central chondrosarcoma
  8. Extracellular vesicles from rat-bone-marrow mesenchymal stromal/stem cells improve tendon repair in rat Achilles tendon injury model in dose-dependent manner: A pilot study
  9. Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma—An Overview
  10. Nrf2-mediated cytoprotective effect of four different hyaluronic acids by molecular weight in human tenocytes
  11. Combined ascorbic acid and T3 produce better healing compared to bone marrow mesenchymal stem cells in an Achilles tendon injury rat model: a proof of concept study
  12. Hyaluronic acid increases tendon derived cell viability and proliferation in vitro: comparative study of two different hyaluronic acid preparations by molecular weight
  13. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
  14. Extracellular Matrix for Tissue Engineering and Biomaterials
  15. RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines
  16. An engineered multiphase 3D microenvironment to ensure the controlled delivery of cyclic strain and hGDF-5 for the tenogenic commitment of hBMSCs
  17. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro
  18. Combined supplementation of ascorbic acid and thyroid hormone T3 affects tenocyte proliferation. The effect of ascorbic acid in the production of nitric oxide
  19. Ewing’s Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue
  20. Hormones and tendinopathies: the current evidence
  21. Influence of Thyroid Hormones on Tendon Homeostasis
  22. Erratum to: Hyaluronic acid increases tendon derived cell viability and collagen type I expression in vitro: Comparative study of four different Hyaluronic acid preparations by molecular weight
  23. Hyaluronic acid increases tendon derived cell viability and collagen type I expression in vitro: Comparative study of four different Hyaluronic acid preparations by molecular weight
  24. Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines
  25. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS)
  26. Thyroid hormones enhance growth and counteract apoptosis in human tenocytes isolated from rotator cuff tendons
  27. Thyroid hormones increase collagen I and cartilage oligomeric matrix protein (COMP) expression in vitrohuman tenocytes
  28. An integrated route to identifying new pathogenesis-based therapeutic approaches for trisomy 21 (Down Syndrome) following the thought of Jérôme Lejeune
  29. Thyroid hormones enhance growth and counteract apoptosis in human tenocytes isolated from rotator cuff tendons
  30. Stem Cell Technologies Based on Hemangioblast Technology Focusing on Human Blood Cells
  31. Stem Cell Technologies Based on Hemangioblast Technology Focusing on Human Blood Cells
  32. Knock-down of HEXA and HEXB genes correlate with the absence of the immunostimulatory function of HSC-derived dendritic cells
  33. Adult human circulating CD34-Lin-CD45-CD133- cells can differentiate into hematopoietic and endothelial cells
  34. Coordinated involvement of cathepsins S, D and cystatin C in the commitment of hematopoietic stem cells to dendritic cells
  35. Design of novel three-phase PCL/TZ–HA biomaterials for use in bone regeneration applications
  36. Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis
  37. IL-16 Can Synergize With Early Acting Cytokines to Expand Ex Vivo CD34 + Isolated from Cord Blood
  38. CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts
  39. Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models
  40. Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells?
  41. A new human cell line, PDSS-26, from poorly differentiated synovial sarcoma, with unique chromosomal anomalies
  42. Basic fibroblast growth factor mediates its effects on committed myeloid progenitors by direct action and has no effect on hematopoietic stem cells
  43. Functional isolation and characterization of human hematopoietic stem cells
  44. Evaluation of Four Different Methods for Platelet Freezing: In vitro and in vivo Studies
  45. Seven-day Storage of Single Donor Platelets in Polyolefin Bags: Clinical, Biochemical, Morphological and Microbiological Evaluation